{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:07:02Z","timestamp":1794571622615,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MC U142684172"],"award-info":[{"award-number":["MC U142684172"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The link between mutations in collagen genes and the development of Alport Syndrome has been clearly established and a number of animal models, including knock-out mouse lines, have been developed that mirror disease observed in patients. However, it is clear from both patients and animal models that the progression of disease can vary greatly and can be modified genetically. We have identified a point mutation in <jats:italic>Col4a4<\/jats:italic> in mice where disease is modified by strain background, providing further evidence of the genetic modification of disease symptoms. Our results indicate that C57BL\/6J is a protective background and postpones end stage renal failure from 7 weeks, as seen on a C3H background, to several months. We have identified early differences in disease progression, including expression of podocyte-specific genes and podocyte morphology. In C57BL\/6J mice podocyte effacement is delayed, prolonging normal renal function. The slower disease progression has allowed us to begin dissecting the pathogenesis of murine Alport Syndrome in detail. We find that there is evidence of differential gene expression during disease on the two genetic backgrounds, and that disease diverges by 4 weeks of age. We also show that an inflammatory response with increasing MCP-1 and KIM-1 levels precedes loss of renal function.<\/jats:p>","DOI":"10.1038\/s41598-019-56837-6","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T11:02:45Z","timestamp":1577790165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Modification of an aggressive model of Alport Syndrome reveals early differences in disease pathogenesis due to genetic background"],"prefix":"10.1038","volume":"9","author":[{"given":"Sara","family":"Falcone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wisby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Blease","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky","family":"Starbuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve D. M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Scudamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Pusey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W. K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"56837_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/humu.21401","volume":"32","author":"JD Parkin","year":"2011","unstructured":"Parkin, J. D. et al. Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes. Human mutation 32, 127\u2013143, https:\/\/doi.org\/10.1002\/humu.21401 (2011).","journal-title":"Human mutation"},{"key":"56837_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00467-012-2272-z","volume":"28","author":"D Noone","year":"2013","unstructured":"Noone, D. & Licht, C. An update on the pathomechanisms and future therapies of Alport syndrome. Pediatric nephrology 28, 1025\u20131036, https:\/\/doi.org\/10.1007\/s00467-012-2272-z (2013).","journal-title":"Pediatric nephrology"},{"key":"56837_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/ndt\/12.8.1595","volume":"12","author":"JA Jefferson","year":"1997","unstructured":"Jefferson, J. A. et al. Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4). Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 12, 1595\u20131599 (1997).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"56837_CR4","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1083\/jcb.135.5.1403","volume":"135","author":"JH Miner","year":"1996","unstructured":"Miner, J. H. & Sanes, J. R. Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome. The Journal of cell biology 135, 1403\u20131413 (1996).","journal-title":"The Journal of cell biology"},{"key":"56837_CR5","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1097\/01.ASN.0000130562.90255.8F","volume":"15","author":"MN Rheault","year":"2004","unstructured":"Rheault, M. N. et al. Mouse model of X-linked Alport syndrome. Journal of the American Society of Nephrology: JASN 15, 1466\u20131474 (2004).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"56837_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0002-9440(10)64892-4","volume":"160","author":"KL Andrews","year":"2002","unstructured":"Andrews, K. L., Mudd, J. L., Li, C. & Miner, J. H. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. The American journal of pathology 160, 721\u2013730, https:\/\/doi.org\/10.1016\/S0002-9440(10)64892-4 (2002).","journal-title":"The American journal of pathology"},{"key":"56837_CR7","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1681\/ASN.2006020165","volume":"17","author":"JS Kang","year":"2006","unstructured":"Kang, J. S. et al. Loss of alpha3\/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-\/- Alport mice. Journal of the American Society of Nephrology: JASN 17, 1962\u20131969, https:\/\/doi.org\/10.1681\/ASN.2006020165 (2006).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"56837_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/path.2979","volume":"226","author":"M Ryu","year":"2012","unstructured":"Ryu, M., Mulay, S. R., Miosge, N., Gross, O. & Anders, H. J. Tumour necrosis factor-alpha drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis. The Journal of pathology 226, 120\u2013131, https:\/\/doi.org\/10.1002\/path.2979 (2012).","journal-title":"The Journal of pathology"},{"key":"56837_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1172\/JCI39569","volume":"120","author":"M Tanaka","year":"2010","unstructured":"Tanaka, M. et al. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. J Clin Invest 120, 768\u2013777, https:\/\/doi.org\/10.1172\/JCI39569 (2010).","journal-title":"J Clin Invest"},{"key":"56837_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.matbio.2010.03.002","volume":"29","author":"O Gross","year":"2010","unstructured":"Gross, O. et al. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease. Matrix biology: journal of the International Society for Matrix Biology 29, 346\u2013356, https:\/\/doi.org\/10.1016\/j.matbio.2010.03.002 (2010).","journal-title":"Matrix biology: journal of the International Society for Matrix Biology"},{"key":"56837_CR11","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1093\/ndt\/gfh219","volume":"19","author":"O Gross","year":"2004","unstructured":"Gross, O. et al. Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 19, 1716\u20131723, https:\/\/doi.org\/10.1093\/ndt\/gfh219 (2004).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"56837_CR12","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/ki.2014.326","volume":"86","author":"JH Miner","year":"2014","unstructured":"Miner, J. H. Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome. Kidney Int 86, 1081\u20131083, https:\/\/doi.org\/10.1038\/ki.2014.326 (2014).","journal-title":"Kidney Int"},{"key":"56837_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.matbio.2016.08.005","volume":"57-58","author":"D Cosgrove","year":"2017","unstructured":"Cosgrove, D. & Liu, S. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. Matrix biology: journal of the International Society for Matrix Biology 57-58, 45\u201354, https:\/\/doi.org\/10.1016\/j.matbio.2016.08.005 (2017).","journal-title":"Matrix biology: journal of the International Society for Matrix Biology"},{"key":"56837_CR14","doi-asserted-by":"publisher","first-page":"e54817","DOI":"10.1371\/journal.pone.0054817","volume":"8","author":"K Okamura","year":"2013","unstructured":"Okamura, K. et al. Endocytosis of albumin by podocytes elicits an inflammatory response and induces apoptotic cell death. PloS one 8, e54817, https:\/\/doi.org\/10.1371\/journal.pone.0054817 (2013).","journal-title":"PloS one"},{"key":"56837_CR15","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1159\/000124236","volume":"108","author":"S Yoshida","year":"2008","unstructured":"Yoshida, S., Nagase, M., Shibata, S. & Fujita, T. Podocyte injury induced by albumin overload in vivo and in vitro: involvement of TGF-beta and p38 MAPK. Nephron. Experimental nephrology 108, e57\u201368, https:\/\/doi.org\/10.1159\/000124236 (2008).","journal-title":"Nephron. Experimental nephrology"},{"key":"56837_CR16","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1172\/JCI28414","volume":"116","author":"G Jarad","year":"2006","unstructured":"Jarad, G., Cunningham, J., Shaw, A. S. & Miner, J. H. Proteinuria precedes podocyte abnormalities inLamb2-\/- mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest 116, 2272\u20132279, https:\/\/doi.org\/10.1172\/JCI28414 (2006).","journal-title":"J Clin Invest"},{"key":"56837_CR17","doi-asserted-by":"publisher","first-page":"02015","DOI":"10.1152\/ajprenal.00456.2015","volume":"00456","author":"G Jarad","year":"2016","unstructured":"Jarad, G., Knutsen, R. H., Mecham, R. P. & Miner, J. H. Albumin contributes to kidney disease progression in Alport syndrome. Am J Physiol Renal Physiol, ajprenal 00456, 02015, https:\/\/doi.org\/10.1152\/ajprenal.00456.2015 (2016).","journal-title":"Am J Physiol Renal Physiol, ajprenal"},{"key":"56837_CR18","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/j.1523-1755.2004.00964.x","volume":"66","author":"JG van den Berg","year":"2004","unstructured":"van den Berg, J. G., van den Bergh Weerman, M. A., Assmann, K. J., Weening, J. J. & Florquin, S. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 66, 1901\u20131906, https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00964.x (2004).","journal-title":"Kidney Int"},{"key":"56837_CR19","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","volume":"69","author":"SJ Shankland","year":"2006","unstructured":"Shankland, S. J. The podocyte\u2019s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 69, 2131\u20132147, https:\/\/doi.org\/10.1038\/sj.ki.5000410 (2006).","journal-title":"Kidney Int"},{"key":"56837_CR20","first-page":"541","volume":"44","author":"T Seefeldt","year":"1981","unstructured":"Seefeldt, T. et al. Quantitative relationship between glomerular foot process width and proteinuria in glomerulonephritis. Lab Invest 44, 541\u2013546 (1981).","journal-title":"Lab Invest"},{"key":"56837_CR21","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/ndt\/17.11.1897","volume":"17","author":"JC Hood","year":"2002","unstructured":"Hood, J. C. et al. Correlation of histopathological features and renal impairment in autosomal dominant Alport syndrome in Bull terriers. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 17, 1897\u20131908 (2002).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"56837_CR22","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1681\/ASN.V591659","volume":"5","author":"KH Kim","year":"1995","unstructured":"Kim, K. H. et al. Structural-functional relationships in Alport syndrome. Journal of the American Society of Nephrology: JASN 5, 1659\u20131668 (1995).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"56837_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.humpath.2009.08.024","volume":"41","author":"J Jedlicka","year":"2010","unstructured":"Jedlicka, J. et al. Interstitial inflammation in Alport syndrome. Human pathology 41, 582\u2013593, https:\/\/doi.org\/10.1016\/j.humpath.2009.08.024 (2010).","journal-title":"Human pathology"},{"key":"56837_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2353\/ajpath.2008.071149","volume":"173","author":"RM Baleato","year":"2008","unstructured":"Baleato, R. M., Guthrie, P. L., Gubler, M. C., Ashman, L. K. & Roselli, S. Deletion of CD151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane. The American journal of pathology 173, 927\u2013937, https:\/\/doi.org\/10.2353\/ajpath.2008.071149 (2008).","journal-title":"The American journal of pathology"},{"key":"56837_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12444","volume":"7","author":"PK Potter","year":"2016","unstructured":"Potter, P. K. et al. Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. Nat Commun 7, 12444, https:\/\/doi.org\/10.1038\/ncomms12444 (2016).","journal-title":"Nat Commun"},{"key":"56837_CR26","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.2741\/3118","volume":"13","author":"SM Hoelter","year":"2008","unstructured":"Hoelter, S. M. et al. \u201cSighted C3H\u201d mice\u2013a tool for analysing the influence of vision on mouse behaviour? Frontiers in bioscience: a journal and virtual library 13, 5810\u20135823 (2008).","journal-title":"Frontiers in bioscience: a journal and virtual library"},{"key":"56837_CR27","doi-asserted-by":"crossref","unstructured":"Lemmink, H. H., Schroder, C. H., Monnens, L. A. & Smeets, H. J. The clinical spectrum of type IV collagen mutations. Human mutation 9, 477-499, doi:10.1002\/(SICI)1098-1004(1997)9:6<477::AID-HUMU1>3.0.CO;2-# (1997).","DOI":"10.1002\/(SICI)1098-1004(1997)9:6<477::AID-HUMU1>3.0.CO;2-#"},{"key":"56837_CR28","doi-asserted-by":"crossref","unstructured":"Arnold, C. N. et al. Rapid identification of a disease allele in mouse through whole genome sequencing and bulk segregation analysis. Genetics 187, 633-641, doi:genetics.110.124586 (2011).","DOI":"10.1534\/genetics.110.124586"},{"key":"56837_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1017\/S0952523805225166","volume":"22","author":"RM Douglas","year":"2005","unstructured":"Douglas, R. M. et al. Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system. Vis Neurosci 22, 677\u2013684, https:\/\/doi.org\/10.1017\/S0952523805225166 (2005).","journal-title":"Vis Neurosci"},{"issue":"6","key":"56837_CR30","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ki.2013.493","volume":"85","author":"Ron Korstanje","year":"2014","unstructured":"Korstanje, R. et al. A mouse collagen4\u03b14 mutation causing Alport glomerulosclerosis with abnormal collagen \u03b13\u03b14\u03b15(IV) trimers. Kidney Int. 85:1461\u20138, https:\/\/doi.org\/10.1038\/ki.2013.493 (2014).","journal-title":"Kidney International"},{"key":"56837_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2353\/ajpath.2006.050896","volume":"169","author":"VH Rao","year":"2006","unstructured":"Rao, V. H. et al. Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome. The American journal of pathology 169, 32\u201346, https:\/\/doi.org\/10.2353\/ajpath.2006.050896 (2006).","journal-title":"The American journal of pathology"},{"key":"56837_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/path.2505","volume":"218","author":"S Clauss","year":"2009","unstructured":"Clauss, S. et al. Ccl2\/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy. The Journal of pathology 218, 40\u201347, https:\/\/doi.org\/10.1002\/path.2505 (2009).","journal-title":"The Journal of pathology"},{"key":"56837_CR33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/jcp.24267","volume":"228","author":"AI Lim","year":"2013","unstructured":"Lim, A. I., Tang, S. C., Lai, K. N. & Leung, J. C. Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells? Journal of cellular physiology 228, 917\u2013924, https:\/\/doi.org\/10.1002\/jcp.24267 (2013).","journal-title":"Journal of cellular physiology"},{"key":"56837_CR34","doi-asserted-by":"crossref","unstructured":"Kashtan, C. E. et al. Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent. Journal of the American Society of Nephrology: JASN 12, 252\u2013260 (2001).","DOI":"10.1681\/ASN.V122252"},{"key":"56837_CR35","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007030328","author":"DR Abrahamson","year":"2007","unstructured":"Abrahamson, D. R. et al. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects. Journal of the American Society of Nephrology: JASN 18, 2465\u20132472. https:\/\/doi.org\/10.1681\/ASN.2007030328 (2007).","journal-title":"Journal of the American Society of Nephrology: JASN 18, 2465-2472"},{"key":"56837_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.matbio.2005.12.001","volume":"25","author":"R Nishiuchi","year":"2006","unstructured":"Nishiuchi, R. et al. Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix biology: journal of the International Society for Matrix Biology 25, 189\u2013197, https:\/\/doi.org\/10.1016\/j.matbio.2005.12.001 (2006).","journal-title":"Matrix biology: journal of the International Society for Matrix Biology"},{"key":"56837_CR37","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1242\/dev.122.11.3537","volume":"122","author":"JA Kreidberg","year":"1996","unstructured":"Kreidberg, J. A. et al. Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122, 3537\u20133547 (1996).","journal-title":"Development"},{"key":"56837_CR38","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1083\/jcb.200306067","volume":"163","author":"N Chattopadhyay","year":"2003","unstructured":"Chattopadhyay, N., Wang, Z., Ashman, L. K., Brady-Kalnay, S. M. & Kreidberg, J. A. alpha3beta1 integrin-CD151, a component of the cadherin-catenin complex, regulates PTPmu expression and cell-cell adhesion. The Journal of cell biology 163, 1351\u20131362, https:\/\/doi.org\/10.1083\/jcb.200306067 (2003).","journal-title":"The Journal of cell biology"},{"key":"56837_CR39","doi-asserted-by":"publisher","first-page":"e50745","DOI":"10.1371\/journal.pone.0050745","volume":"7","author":"BM Steenhard","year":"2012","unstructured":"Steenhard, B. M. et al. Upregulated expression of integrin alpha1 in mesangial cells and integrin alpha3 and vimentin in podocytes of Col4a3-null (Alport) mice. PloS one 7, e50745, https:\/\/doi.org\/10.1371\/journal.pone.0050745 (2012).","journal-title":"PloS one"},{"key":"56837_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1681\/ASN.2010030321","volume":"22","author":"S Rong","year":"2011","unstructured":"Rong, S. et al. The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury. Journal of the American Society of Nephrology: JASN 22, 484\u2013495, https:\/\/doi.org\/10.1681\/ASN.2010030321 (2011).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"56837_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/srep29450","volume":"6","author":"T Murata","year":"2016","unstructured":"Murata, T. et al. COL4A6 is dispensable for autosomal recessive Alport syndrome. Sci Rep 6, 29450, https:\/\/doi.org\/10.1038\/srep29450 (2016).","journal-title":"Sci Rep"},{"key":"56837_CR42","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1681\/ASN.2014040419","volume":"26","author":"MJ Randles","year":"2015","unstructured":"Randles, M. J. et al. Genetic Background is a Key Determinant of Glomerular Extracellular Matrix Composition and Organization. Journal of the American Society of Nephrology: JASN 26, 3021\u20133034, https:\/\/doi.org\/10.1681\/ASN.2014040419 (2015).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"56837_CR43","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ki.2013.45","volume":"83","author":"DA Long","year":"2013","unstructured":"Long, D. A. et al. Albuminuria is associated with too few glomeruli and too much testosterone. Kidney Int 83, 1118\u20131129, https:\/\/doi.org\/10.1038\/ki.2013.45 (2013).","journal-title":"Kidney Int"},{"key":"56837_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nature10413","volume":"477","author":"TM Keane","year":"2011","unstructured":"Keane, T. M. et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477, 289\u2013294, https:\/\/doi.org\/10.1038\/nature10413 (2011).","journal-title":"Nature"},{"key":"56837_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000355758","volume":"38","author":"YX Gao","year":"2013","unstructured":"Gao, Y. X. et al. ADAMTS-7 expression increases in the early stage of angiotensin II-induced renal injury in elderly mice. Kidney Blood Press Res 38, 121\u2013131, https:\/\/doi.org\/10.1159\/000355758 (2013).","journal-title":"Kidney Blood Press Res"},{"key":"56837_CR46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1159\/000321366","volume":"32","author":"T Murakami","year":"2010","unstructured":"Murakami, T. et al. Trophoblast glycoprotein: possible candidate mediating podocyte injuries in glomerulonephritis. Am J Nephrol 32, 505\u2013521, https:\/\/doi.org\/10.1159\/000321366 (2010).","journal-title":"Am J Nephrol"},{"key":"56837_CR47","doi-asserted-by":"publisher","first-page":"F1099","DOI":"10.1152\/ajprenal.00251.2012","volume":"303","author":"SE Chase","year":"2012","unstructured":"Chase, S. E. et al. Podocyte-specific knockout of myosin 1e disrupts glomerular filtration. Am J Physiol Renal Physiol 303, F1099\u20131106, https:\/\/doi.org\/10.1152\/ajprenal.00251.2012 (2012).","journal-title":"Am J Physiol Renal Physiol"},{"key":"56837_CR48","doi-asserted-by":"publisher","first-page":"F532","DOI":"10.1152\/ajprenal.00223.2013","volume":"305","author":"J Bi","year":"2013","unstructured":"Bi, J. et al. Myosin 1e is a component of the glomerular slit diaphragm complex that regulates actin reorganization during cell-cell contact formation in podocytes. Am J Physiol Renal Physiol 305, F532\u2013544, https:\/\/doi.org\/10.1152\/ajprenal.00223.2013 (2013).","journal-title":"Am J Physiol Renal Physiol"},{"key":"56837_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1681\/ASN.2007111172","volume":"20","author":"M Krendel","year":"2009","unstructured":"Krendel, M. et al. Disruption of Myosin 1e promotes podocyte injury. Journal of the American Society of Nephrology: JASN 20, 86\u201394, https:\/\/doi.org\/10.1681\/ASN.2007111172 (2009).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"56837_CR50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/ki.2011.148","volume":"80","author":"S Sanna-Cherchi","year":"2011","unstructured":"Sanna-Cherchi, S. et al. Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. Kidney Int 80, 389\u2013396, https:\/\/doi.org\/10.1038\/ki.2011.148 (2011).","journal-title":"Kidney Int"},{"key":"56837_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1056\/NEJMoa1101273","volume":"365","author":"C Mele","year":"2011","unstructured":"Mele, C. et al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med 365, 295\u2013306, https:\/\/doi.org\/10.1056\/NEJMoa1101273 (2011).","journal-title":"N Engl J Med"},{"key":"56837_CR52","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00467-015-3067-9","volume":"30","author":"R Lennon","year":"2015","unstructured":"Lennon, R. et al. Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease. Pediatric nephrology 30, 1459\u20131465, https:\/\/doi.org\/10.1007\/s00467-015-3067-9 (2015).","journal-title":"Pediatric nephrology"},{"key":"56837_CR53","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1083\/jcb.130.5.1219","volume":"130","author":"Y Ninomiya","year":"1995","unstructured":"Ninomiya, Y. et al. Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. The Journal of cell biology 130, 1219\u20131229 (1995).","journal-title":"The Journal of cell biology"},{"key":"56837_CR54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/01926230252824761","volume":"30","author":"C Shackelford","year":"2002","unstructured":"Shackelford, C., Long, G., Wolf, J., Okerberg, C. & Herbert, R. Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol Pathol 30, 93\u201396, https:\/\/doi.org\/10.1080\/01926230252824761 (2002).","journal-title":"Toxicol Pathol"},{"key":"56837_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0304-3940(02)00223-9","volume":"325","author":"C Thaung","year":"2002","unstructured":"Thaung, C., Arnold, K., Jackson, I. J. & Coffey, P. J. Presence of visual head tracking differentiates normal sighted from retinal degenerate mice. Neurosci Lett 325, 21\u201324 (2002).","journal-title":"Neurosci Lett"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56837-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56837-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56837-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T18:20:05Z","timestamp":1671301205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56837-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56837"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56837-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,31]]},"assertion":[{"value":"31 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. F.W.K.T. has received research project grants from AstraZeneca Limited, Baxter Biosciences, Boehringer Ingelheim, and MedImmune, and has consultancy agreements with Rigel Pharmaceuticals, Novartis and Baxter Biosciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20398"}}